Insider Trading Activity For Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)
Eastern Capital Ltd , Major Shareholder of Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) reportedly Bought 850,000 shares of the company’s stock at an average price of 2 for a total transaction amount of $1,700,000.00 SEC Form
Insider Trading History For Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)
On 5/21/2013 Spiro George Rombotis, Insider, bought 100,000 with an average share price of $3.00 per share and the total transaction amounting to $300,000.00.View SEC Filing
On 5/21/2013 Paul Mcbarron, CFO, bought 12,948 with an average share price of $3.03 per share and the total transaction amounting to $39,232.44.View SEC Filing
On 5/21/2013 Lloyd Sems, Director, bought 33,333 with an average share price of $3.00 per share and the total transaction amounting to $99,999.00.View SEC Filing
On 11/20/2014 Sam L Barker, Director, bought 3,100 with an average share price of $3.00 per share and the total transaction amounting to $9,300.00.View SEC Filing
On 2/23/2017 Kevin C Tang, Major Shareholder, bought 134,200 with an average share price of $4.34 per share and the total transaction amounting to $582,428.00.View SEC Filing
On 7/19/2017 Eastern Capital Ltd, Major Shareholder, bought 850,000 with an average share price of $2.00 per share and the total transaction amounting to $1,700,000.00.View SEC Filing
Analyst Ratings For Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)
These are 1 Buy Rating .
The current consensus rating for Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) is Buy (Score: 3.00) with a consensus target price of N/A
Analyst Ratings History For Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)
- On 8/12/2016 HC Wainwright Reiterated Rating Buy
Dividend History For Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)
On 6/9/2016 Cyclacel Pharmaceuticals, Inc. announced a Annual dividend of $0.15 with an ex dividend date of 7/13/2016 which will be payable on 8/1/2016.
Recent Trading Activity for Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)
Shares of Cyclacel Pharmaceuticals, Inc. closed the previous trading session at 1.91 up +0.14 8.22% with 2,618,845 shares trading hands.